NADPH oxidase inhibitor (Georgia Institute of Technology/Emory University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNADPH oxidase inhibitor (Georgia Institute of Technology/Emory University)
Drug Alias Nameimipramine blueImipramine blue (Georgia Institute of Technology/Emory University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActin modulatorsNADPH oxidase inhibitors
TargetsNADPH oxidaseActin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgia Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory UniversityGeorgia Institute Of Technology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A